Tag: chemotherapy

In the face of a loved one’s cancer diagnosis, you may wonder how you could possibly help. You want to support them through their battle, but you just don’t know how. As they try to cope with the diagnosis, surgeries and treatments, here are five ways you can support and encourage your loved one in … Continue reading 5 ways you can support a loved one with cancer

Patients with pancreatic cancer might consider joining a Phase II clinical trial underway at Baylor University Medical Center at Dallas to evaluate a new chemotherapy protocol. The trial will study the effectiveness of a particular therapy in patients with non-metastatic disease. “Our primary objective with this trial is to try to control micrometastatic disease,” said … Continue reading Evaluating New Chemotherapy Protocols Through Clinical Trials

At 21 years old I was living my perfect life. I had a three-year-old son, a godly man by my side, a job I cherished as a police dispatcher, and I was an avid softball player, so my health was never a concern. In November 2007, a walnut-sized lump on the left side of my … Continue reading Celebrating a “Cancerversary” With a Tattoo

Imagine a world without routine colonoscopies. Because of a new blood test we developed at Baylor Research Institute, this could potentially become a reality. Our team of researchers at the Gastrointestinal Cancer Research Lab has spent the last several years working on the discovery and validation of biomarkers that can facilitate the early detection of … Continue reading New Blood Test Could Eliminate the Need for Screening Colonoscopies

My name is Laura Wassef. I am married to my high school sweetheart. I am a mother of three, the oldest 13-years old. I am a sister, daughter, niece, aunt, cousin and friend, and a breast cancer survivor. This is my story. January 2011, just a few days before my 42nd birthday, I was diagnosed with … Continue reading Breast Cancer Was a Detour for Me

Targeted therapy for ovarian cancer has been an elusive goal for researchers for many years because ovarian cancer is a heterogeneous disease, exhibiting a plethora of genetic alterations. In a small percentage of patients, the cancer is found to be hereditary. In these patients, mutations in the BRCA gene lead to an increased risk of ovarian, … Continue reading Ovarian Cancer’s Vulnerability Exposed: Clinical Trial Offers New Hope

The experimental drug, T-DM1, also known as the breast cancer “smart bomb,” is a phrase that’s been on everyone’s lips and search engines since Monday when it was announced as the “miracle drug” breast cancer treatment. Kimberly Blackwell, M.D., an oncologist at Duke University Medical Center and lead investigator of the T-DM1 study, presented her … Continue reading 4 Things to Know About The New Breast Cancer “Smart Bomb”

The Journal of Clinical Oncology published an online article, Feb. 27, looking at a study about “chemo brain”, the name given to the mental fog and related memory problems that can occur during and after chemotherapy. The study looked at women, between ages 50 to 80, who had been treated with chemotherapy for breast cancer … Continue reading What is Chemo Brain?